Home » Regeneron Announces Strong Results in Gout Study
Regeneron Announces Strong Results in Gout Study
Regeneron Pharmaceuticals of Tarrytown, N.Y., announced positive results from a second late-stage clinical trial showing that its drug Arcalyst, currently approved for a rare disease, can treat gout, a much more lucrative opportunity.
Forbes
Forbes
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May